Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0018372
DC FieldValue
dc.titleSall4, a stem cell factor, affects the side population by regulation of the atp-binding cassette drug transport genes
dc.contributor.authorJeong, H.-W.
dc.contributor.authorCui, W.
dc.contributor.authorYang, Y.
dc.contributor.authorLu, J.
dc.contributor.authorHe, J.
dc.contributor.authorLi, A.
dc.contributor.authorSong, D.
dc.contributor.authorGuo, Y.
dc.contributor.authorLiu, B.H.
dc.contributor.authorChai, L.
dc.date.accessioned2014-11-26T10:00:12Z
dc.date.available2014-11-26T10:00:12Z
dc.date.issued2011
dc.identifier.citationJeong, H.-W., Cui, W., Yang, Y., Lu, J., He, J., Li, A., Song, D., Guo, Y., Liu, B.H., Chai, L. (2011). Sall4, a stem cell factor, affects the side population by regulation of the atp-binding cassette drug transport genes. PLoS ONE 6 (4) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0018372
dc.identifier.issn19326203
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110783
dc.description.abstractOur previous work shows that the stem cell factor SALL4 plays a central role in embryonic and leukemic stem cells. In this study, we report that SALL4 expression was higher in drug resistant primary acute myeloid leukemic patients than those from drug-responsive cases. In addition, while overexpression of SALL4 led to drug resistance in cell lines, cells with decreased SALL4 expression were more sensitive to drug treatments than the parental cells. This led to our investigation of the implication of SALL4 in drug resistance and its role in side population (SP) cancer stem cells. SALL4 expression was higher in SP cells compared to non-SP cells by 2-4 fold in various malignant hematopoietic cell lines. Knocking down of SALL4 in isolated SP cells resulted in a reduction of SP cells, indicating that SALL4 is required for their self-renewal. The SP phenotype is known to be mediated by members of the ATP-binding cassette (ABC) drug transport protein family, such as ABCG2 and ABCA3. Using chromatin-immunoprecipitation (ChIP), quantitative reverse transcription polymerase chain reaction (qRT-PCR) and electrophoretic mobility shift assay(EMSA), we demonstrated that SALL4 was able to bind to the promoter region of ABCA3 and activate its expression while regulating the expression of ABCG2 indirectly. Furthermore, SALL4 expression was positively correlated to those of ABCG2 and ABCA3 in primary leukemic patient samples. Taken together, our results suggest a novel role for SALL4 in drug sensitivity, at least in part through the maintenance of SP cells, and therefore may be responsible for drug-resistance in leukemia. We are the first to demonstrate a direct link between stem cell factor SALL4, SP and drug resistance in leukemia. © 2011 Jeong et al.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1371/journal.pone.0018372
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.description.doi10.1371/journal.pone.0018372
dc.description.sourcetitlePLoS ONE
dc.description.volume6
dc.description.issue4
dc.description.page-
dc.identifier.isiut000289671100003
dc.published.statePublished
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0018372.pdf768.94 kBAdobe PDF

OPEN

PublishedView/Download

SCOPUSTM   
Citations

52
checked on Sep 21, 2021

WEB OF SCIENCETM
Citations

55
checked on Sep 21, 2021

Page view(s)

85
checked on Sep 23, 2021

Download(s)

2
checked on Sep 23, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.